Antimetabolites for cancer treatment
17,602views

00:00 / 00:00
Flashcards
Antimetabolites for cancer treatment
0 of 69 complete
Questions
USMLE® Step 1 style questions USMLE
0 of 2 complete
USMLE® Step 2 style questions USMLE
0 of 7 complete
Memory Anchors and Partner Content
External References
First Aid
2024
2023
2022
2021
Acute lymphoblastic leukemia (ALL) p. 437
methotrexate for p. 443
Choriocarcinomas
methotrexate for p. 443
Ectopic pregnancy p. NaN
methotrexate for p. 444
Hepatotoxicity
methotrexate p. 444
Inflammatory bowel disease (IBD) p. 389
methotrexate for p. 443
Lymphoma
methotrexate for p. 443
Medical abortion
methotrexate for p. 444
Methotrexate p. 443
in cell cycle p. 443
folate deficiency p. 426
hydatidiform moles p. 656
megaloblastic anemia p. 249
polymyositis/dematomyositis p. 479
pulmonary fibrosis p. 250
pyrimidine synthesis and p. 34
rheumatoid arthritis p. 472
targets of p. 443
teratogenicity p. 632
toxicities of p. 445, 694
vitamin BNaN deficiency p. 66
as weak acid p. 231
Mucositis
methotrexate p. 444
Psoriasis p. 485
methotrexate for p. 444
Pulmonary fibrosis
methotrexate p. 444
Rheumatoid arthritis p. 472
methotrexate for p. 444
Sarcomas
methotrexate for p. 444
Vasculitis
methotrexate for p. 444
External Links
Transcript
Content Reviewers
Antimetabolites are a diverse group of medications that are used for the treatment of various conditions including cancer, infections and autoimmune disorders.
In this video, we are focusing on the antimetabolites used in cancer treatment.
Alright, during the S phase of the cell cycle, the cell performs DNA replication.
DNA is composed of a sequence of deoxyribonucleotides and each deoxyribonucleotide is made out of a phosphate group, a five carbon sugar like deoxyribose, and a nucleobase, which can be either a pyrimidine like cytosine, or thymidine, or a purine like adenine or guanine.
Now, nucleotide synthesis starts with ribose-5-phosphate, which is specific for RNA, and an enzyme called ribose phosphate pyrophosphokinase uses an ATP to remove two phosphate groups from it, attaching them to ribose-5-phosphate, creating a phosphoribosyl pyrophosphate, or PRPP.
Because it catalyzes the synthesis of PRPP, the enzyme ribose phosphate pyrophosphokinase is also known as PRPP synthetase.
Next step is to make pyrimidines. The amino acid glutamine, bicarbonate, and water are used to form a molecule called carbamoyl phosphate which is then joined to aspartate and together, they form a ringed molecule called carbamoyl aspartic acid, which gets dehydrated to create a molecule called orotate.
Next, an enzyme moves the phosphoribose unit from PRPP to orotate and that forms orotidine monophosphate, or OMP.
Next, the enzyme UMP synthase converts orotidine monophosphate into uridine monophosphate, or UMP.
That UMP gets phosphorylated twice by nucleoside diphosphate kinase, to become uridine triphosphate, or UTP.
Finally, the enzyme CTP synthase, converts uridine triphosphate into cytidine triphosphate, or CTP.
Now, purine synthesis starts with the amino acids glutamine, aspartate, and glycine, together with bicarbonate and formate, which is the anion derived from formic acid.
These undergo a ten-step pathway and the result is inosine monophosphate, or IMP, which is sort of a generic purine.
IMP can be converted to AMP and GMP.
Okay, RNA nucleotides are usually in the monophosphate form, but to get to DNA nucleotides, we need them in the diphosphate form, so CDP, UDP, ADP, and GDP.
Next, an enzyme called ribonucleotide diphosphate reductase will reduce the ribose within them into deoxyribose, creating dCDP, dUDP dADP, and dGDP.
After this, they just need to lose a phosphate group, and we’ll have dCMP, dUMP, dAMP, and dGMP.
But, something is missing - dTMP. And here comes the folic acid, or vitamin B9, which is converted to tetrahydrofolic acid, or THF.
Sources
- "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2019)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
- "Nomograms" D. Nicoll , C. Mark Lu, S.J. McPhee (Eds.), Guide to Diagnostic Tests, 7e. McGraw-Hill (2017)
- "Overview of hemostasis" J.C. Aster, H. Bunn (Eds.), Pathophysiology of Blood Disorders, 2e. McGraw-Hill. (2016)
- "Cytotoxic-induced heart failure among breast cancer patients in Nigeria: A call to prevent today's cancer patients from being tomorrow's cardiac patients" Annals of African Medicine (2020)
- "Clinical potential of midostaurin in advanced systemic mastocytosis" Blood and Lymphatic Cancer: Targets and Therapy (2017)